FDA faults Celltrion plant that makes Pfizer's Remicade copy, Inflectra
admin 14th September 2017 Uncategorised 0Pfizer is leaning heavily on Celltrion for its biosimilar development and manufacturing, but its South Korean partner has stumbled with an FDA inspection that uncovered issues at its plant in Incheon.
More: FDA faults Celltrion plant that makes Pfizer's Remicade copy, Inflectra
Source: fierce